Expert Interview
A look at the topline results of the Phase 2 MISSION trial of zetomipzomib in Lupus Nephritis patients
Ticker(s): KZR, AUPHInstitution: Albert Einstein College of Medicine | Montefiore
- Nephrologist & Professor of Medicine at Albert Einstein College of Medicine.
- Manages 80 patients with Lupus Nephritis and 125 patients with anemia on dialysis and hundreds with anemia and CKD not on dialysis
- Has published over 100 manuscript and book chapters and practice focuses on nephrology and dialysis.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
